Skip to main

Akoustis Technologies

AKTS is nowAKTSQ
AKTS logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for AKTS stock is $200

The 52-week high for AKTS stock is $0.10. The current AKTS stock price $undefined is 100.00% below its 52-week high

No, the AKTS stock does not pay dividends to its shareholders

How to buy AKTS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AKTS stock

    Navigate to the Explore page. Then, type AKTS into the search bar. When you see AKTS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AKTS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Akoustis Technologies Stock Earnings

The value each AKTS share was expected to gain vs. the value that each AKTS share actually gained.

Akoustis Technologies (AKTS) reported Q1 2025 earnings per share (EPS) of -$0.04, beating estimates of -$0.11 by 63.64%. In the same quarter last year, Akoustis Technologies's earnings per share (EPS) was -$0.27. Akoustis Technologies is expected to release next earnings on 11/14/2024, with an earnings per share (EPS) estimate of $0.

Buy Akoustis Technologies (AKTS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.